Search database
LIST OPTIONS
Filter
102
Filtered Results: 102
Text search: heterologous
Featured
Language
Document type
Guidelines
40
No document type
32
Studies & Reports
13
Manuals
5
Fact sheets
5
Strategic & Response Plan
4
Situation Updates
2
Infographics
1
Countries / Regions
Brazil
8
India
6
Argentina
5
Africa
3
Latin America and the Carribbean
3
South Africa
3
Nigeria
2
Mozambique
2
Paraguay
2
Bolivia
2
Russia
2
Chile
1
Philippines
1
Global
1
Asia
1
Tanzania
1
Germany
1
East and Southern Africa
1
Uganda
1
Indonesia
1
Ecuador
1
Authors & Publishers
World Health Organization WHO
35
Ministerio de Salud Argentina
4
OPAS
4
World Health Organization
4
Abela-Ridder, B.
2
Dirección de Control de Enfermedades Inmunoprevenibles
2
Federal Ministry of Health, Nigeria
2
Feraud, H.
2
Indian Council of Medical Research
2
Organisation Mondiale de la Santé OMS
2
Organización Mundial de la Salud OMS
2
Organización Mundial de Saude and OPAS
2
Organização Mundial da Saúde (OMS)
2
Rupprecht, C.
2
WHO
2
World Health Organisation (WHO)
2
World Health Organization (WHO)
2
World Heart Federation
2
Abubakar, B.K.
1
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
Ahmad, U., Chau, D.M. et al.
1
Bill & Melinda Gates Foundation
1
BioMed Central
1
BMC Part of Springer Nature
1
BooMed Central
1
Dept. of Health South Africa
1
Dra. María Cristina San Miguel de Vera
1
E. Malchiodi, J.P. Ioset, et al.
1
Elsevier Ltd.
1
Erwinanto, A. Santoso, J. N. E. Putranto, et al.,
1
Fairlamb, A.H.
1
Ference, B.A.
1
Fooks, A,
1
Fooks, A.
1
Garratt, A.
1
Gavi, the Vaccine Alliance
1
Gerald Keusch, Keith McAdam, Patricia Cuff, Michelle Mancher, and Emily R. Busta
1
Guo, J.
1
HelpAge
1
Hill, A.
1
Hindawi Publishing Corporation
1
Horn, D.
1
IACAPAP
1
Ibarra-Cerdena, C.
1
Indonesian Heart Association
1
Izeta-Alberdi, A.
1
J. A. Triccas, C. Counoupas
1
J. J. C. Nuttal, B. S. Eley
1
Jara A., Undurraga E. A. et al
1
JCI insight
1
Journal of Cystic Fibrosis
1
Journal of Movements Disorders
1
Logunov, D.Y, et al.
1
M. A. Gasper, A. C. Hesseling, I. Mohar, et al.
1
Ministerio da Saude Brasilia
1
Ministerio de Salud
1
Ministerio de Salud Bolivia
1
Ministerio de Salud Pública de Ecuador
1
Ministerio de Salud Pública, Paraguay
1
Ministerio de Salud, Argentina
1
Ministério da Saúde, Brasil
1
Ministry of Health & Family Welfare India
1
Moo-llanes, D.
1
Muntean Al., Popa M.
1
National Academies of Sciences, Engineering, and Medicine
1
National Centre for Disease Control
1
National Department of Health, South Africa
1
National Health Mission (NHM), Ministry of Health & Family Welfare, Government of India
1
National Institue of communicable Diseases, India
1
National Rabies Programme
1
O. Bandmann
1
OPAS, OMS
1
OPS
1
Organización Panamericana de la Salud
1
Pan American Health Organisation PAHO
1
Pan American Health Organization PAHO
1
Pinazo, M.J.
1
Pneumonia
1
Popa G.
1
R. R. Althoff
1
R. Walker
1
Ramsey,J.
1
Ray, K.K.
1
RCC Service
1
Saudi Journal of Biological Sciences
1
Secretaria Extraordinária de Enfrentamento à COVID-19, Brasil
1
Séverin, T. et al.
1
TDR
1
Trials
1
U. Williams
1
UNICEF
1
V. Nankabirwa , J. K. Tumwine, O. Namugga, et al.
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
World Health Organization WHO, Regional Office of Africa
1
World Health Organization WHO, SAGE
1
World Health Organization, Regional Office for the Americas
1
Publication Years
Category
Countries
34
Clinical Guidelines
11
Public Health
4
Pharmacy & Technologies
3
Capacity Building
1
Women & Child Health
1
Toolboxes
COVID-19
48
NTDs
8
Rapid Response
5
TB
4
NCDs
3
Mental Health
2
Zika
2
Ebola & Marburg
1
Planetary Health
1
Pharmacy
1
Health Financing Toolbox
1
Polio
1
Global Health Education
1
Overview 16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
A Organização Mundial da Saúde (OMS), com apoio do Grupo Consultivo Estratégico de Especialistas em Imunização (Strategic Advisory Group of Experts on Immunization – SAGE) e do respectivo Grupo de Trabalho para Vacinas contra a COVID-19, está analisando novas evidências sobre o uso de vaci... more
21 January 2022 The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian... more
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so... more
Временное руководство (‎Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
This algorithm is addressed to laboratories with established capacity(molecular, antigenic and/orserological) to detect dengue (DENV), Zika (ZIKV), and chikungunya(CHIKV) as part of the differential diagnosis for arborviruses. A BSL2 containment level is required to handle suspected samples.
7 August 2021
Clinical Medicine JCI Insight. 2017;2(7):e91963.
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below. This document has been updat... more
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ... more
Guidelines for Management and Treatment of Dyslipidemia in Indonesia
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p... more
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma... more
Guidelines for the Vaccination Scheme against COVID 19: Booster Dose Health Personnel
Este algoritmo está dirigido a aquellos laboratorios que cuentan con capacidad instalada para la detección (molecular, antigénica y/o serológica) de dengue (DENV), Zika (ZIKV) y chikungunya(CHIKV),y como parte del diagnóstico diferencial para Arbovirus. Para la manipulación de muestras sosp... more
Additional dose of the primary vaccination against COVID-19: Technical Guidelines
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de... more
Campaña Nacional de Vacunación contra la COVID-19